Home›People›Kirk Nielsen
KN

Kirk Nielsen

Director at CVRx. Also a director at Okami Medical, VI1 and SpyGlassPharma.

DirectorPublic companyRoles at 3 startups
Updated Nov 9, 2026·Latest SEC filing Jun 3, 2026·Suggest an edit

About Kirk Nielsen

Kirk Nielsen is a director at CVRx.

Form D filings name Kirk Nielsen as a director at Okami Medical, VI1 and SpyGlassPharma.

Kirk Nielsen reports to the SEC as a director or major shareholder of 3 public companies, including SpyGlass Pharma (SGP) and Inari Medical (NARI).

Kirk Nielsen first appears on SEC filings in 2020.

Experience

This experience comes from SEC filings. The years are when the filings name Kirk Nielsen in the role, so the role may have started earlier or lasted longer.

CVRx, Inc.
Director
2021 – 2026 · Public company (CVRX)
SpyGlassPharma, Inc.
Director and 10% owner
2021 – 2026 · Public company (SGP)
Okami Medical, Inc.
Director
2025 · Aliso Viejo, CA
VI1, Inc.
Director
2025 · Edina, MN
Inari Medical, Inc.
Director and 10% owner
2020 – 2023 · Public company (NARI)

Key Colleagues at Startups

The people Kirk Nielsen works with at each company, as listed on that company's latest Form D.

Okami Medical, Inc. · Form D, Dec 1, 2025
JR
DM
MK
Mike Kramer
Director
WH
AH
Andrew Hykes
Chief Executive Officer and director
PL
Paul Lubock
Director
VI1, Inc. · Form D, Aug 15, 2025
TT
Thomas Tu
Executive officer
WH
William Hoffman
Executive officer
SS
Steven Schwen
Chief Financial Officer
MB
SpyGlassPharma, Inc. · Form D, Jan 5, 2021
MK
Malik Kahook
Executive officer and director
AB
TC
Tak Cheung
Director
CY
Cynthia Yee
Director
GS
Glenn Sussman
Chief Executive Officer and director

Sources

  1. SECOkami Medical, Inc. Form D, filed Dec 1, 2025
  2. SECVI1, Inc. Form D, filed Aug 15, 2025
  3. SECSpyGlassPharma, Inc. Form D, filed Jan 5, 2021
  4. SECForms 3, 4 and 5 filed by Kirk Nielsen (SEC filer 1523522)